losartan/hydrochlorothiazide stada 100 mg/12,5 mg apvalkotās tabletes
stada arzneimittel ag, germany - losartanum kalicum, hydrochlorothiazidum - apvalkotā tablete - 100 mg/12,5 mg
losartan/hydrochlorothiazide stada 100 mg/25 mg apvalkotās tabletes
stada arzneimittel ag, germany - losartanum kalicum, hydrochlorothiazidum - apvalkotā tablete - 100 mg/25 mg
irbesartan/hydrochlorothiazide teva
teva b.v. - irbesartan, hydrochlorothiazide - hipertensija - agents, kas iedarbojas uz renīna-angiotenzīna sistēmu - esenciālas hipertensijas ārstēšana. Šī fiksēto devu kombinācija ir indicēta pieaugušiem pacientiem, kuru asinsspiediens nav pietiekami kontrolēts, lietojot irbesartānu vai tikai hidrohlortiazīdu.
irbesartan hydrochlorothiazide zentiva (previously irbesartan hydrochlorothiazide winthrop)
sanofi-aventis groupe - irbesartan, hydrochlorothiazide - hipertensija - agents, kas iedarbojas uz renīna-angiotenzīna sistēmu - esenciālas hipertensijas ārstēšana. Šī fiksēto devu kombinācija ir indicēta pieaugušiem pacientiem, kuru asinsspiediens nav pietiekami kontrolēts, lietojot irbesartānu vai tikai hidrohlortiazīdu.
sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - cukura diabēts, 2. tips - cukura diabēts - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , triple kombinēto terapiju), kā palīglīdzekli, lai diētu un vingrošanu pacientiem nepietiekami kontrolē par to maksimālā pieļaujama devu metformīns un sulfonilurīnvielas pamata. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
hydrogenium peroxydatum hasco 3% šķīdums
p.p.f. hasco-lek s.a., poland - ūadeņražea peroksīds - uz ādas lietojams šķīdums - 3%
olmesartan medoxomil/amlodipine/hydrochlorothiazide teva 20 mg/5 mg/12,5 mg apvalkotās tabletes
teva b.v., netherlands - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - apvalkotā tablete - 20 mg/5 mg/12,5 mg
olmesartan medoxomil/amlodipine/hydrochlorothiazide teva 40 mg/5 mg/12,5 mg apvalkotās tabletes
teva b.v., netherlands - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - apvalkotā tablete - 40 mg/5 mg/12,5 mg
olmesartan medoxomil/amlodipine/hydrochlorothiazide teva 40 mg/10 mg/12,5 mg apvalkotās tabletes
teva b.v., netherlands - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - apvalkotā tablete - 40 mg/10 mg/12,5 mg
olmesartan medoxomil/amlodipine/hydrochlorothiazide accord 20 mg/5 mg/12,5 mg apvalkotās tabletes
accord healthcare b.v., netherlands - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - apvalkotā tablete - 20 mg/5 mg/12,5 mg